Literature DB >> 9393198

Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors.

D A Zuckerman1, M D Darcy, T P Bocchini, C F Hildebolt.   

Abstract

OBJECTIVE: Our purpose was to estimate the incidence of encephalopathy after transjugular intrahepatic portosystemic shunting (TIPS) related primarily to the diversion of portal vein blood flow and to identify periprocedural factors to predict patients at risk.
MATERIALS AND METHODS: All patients who underwent TIPS with at least 1 month of clinical observation after the procedure were monitored for clinically evident encephalopathy. Other variables that could individually induce encephalopathy were retrospectively analyzed for interrelationships with spontaneous or worsened encephalopathy.
RESULTS: Of the 150 patients, 68 (45%) suffered from encephalopathy after TIPS, but in only 33 (22%) was it new or worse than baseline measurements obtained before TIPS; in 18 of these 33 patients, an underlying medical cause was implicated. Fifteen (10%) of the 150 patients developed mental dysfunction, usually mild and well controlled, thought to be related only to TIPS and not to any underlying morbidity. Low portal vein pressures after TIPS were found to be interrelated with new or worsened spontaneous encephalopathy (p = .04). Like-wise, advanced age (> 59 years old) weakly corresponded to the development of encephalopathy after TIPS.
CONCLUSION: TIPS causes an acceptably low rate of encephalopathy that is usually mild. No specific variables exist for predicting the development or progression of encephalopathy after TIPS.

Entities:  

Mesh:

Year:  1997        PMID: 9393198     DOI: 10.2214/ajr.169.6.9393198

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

1.  Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE.

Authors:  Gil Weitzman; Neil J Schamberg; Gerond Lake-Bakaar
Journal:  Dig Dis Sci       Date:  2007-07-20       Impact factor: 3.199

2.  Transjugular intrahepatic portosystemic shunts in patients with hepatic malignancy.

Authors:  Michael J Wallace; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

3.  Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.

Authors:  David C Madoff; Michael J Wallace
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

4.  Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Silvia Nardelli; Stefania Gioia; Chiara Pasquale; Ilaria Pentassuglio; Alessio Farcomeni; Manuela Merli; Filippo Maria Salvatori; Leandra Nikolli; Sabrina Torrisi; Francesca Greco; Valeria Nicoletti; Oliviero Riggio
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

5.  No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Authors:  Oliviero Riggio; Silvia Nardelli; Chiara Pasquale; Ilaria Pentassuglio; Stefania Gioia; Eugenia Onori; Camilla Frieri; Filippo Maria Salvatori; Manuela Merli
Journal:  Metab Brain Dis       Date:  2015-08-20       Impact factor: 3.584

6.  Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites.

Authors:  Ahmad Parvinian; James T Bui; M Grace Knuttinen; Jeet Minocha; Ron C Gaba
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

7.  Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.

Authors:  Paolo Fonio; Andrea Discalzi; Marco Calandri; Andrea Doriguzzi Breatta; Laura Bergamasco; Silvia Martini; Antonio Ottobrelli; Dorico Righi; Giovanni Gandini
Journal:  Radiol Med       Date:  2017-05-16       Impact factor: 3.469

8.  Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.

Authors:  Zai-Bo Jiang; Hong Shan; Xin-Ying Shen; Ming-Sheng Huang; Zheng-Ran Li; Kang-Shun Zhu; Shou-Hai Guan
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 9.  TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.

Authors:  Ming Bai; Xing-Shun Qi; Zhi-Ping Yang; Man Yang; Dai-Ming Fan; Guo-Hong Han
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt Placement.

Authors:  Michael W Rowley; Myunghan Choi; Steve Chen; Kevin Hirsch; Anil B Seetharam
Journal:  J Clin Exp Hepatol       Date:  2017-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.